Empyrean Neuroscience is a New York-based genetic engineering company that develops small molecule therapeutics from fungi and plants to treat a range of neuropsychiatric and neurologic disorders. Founded in 2022, the company focuses on anxiety & stress disorders, post-traumatic stress diseases, and neurodegenerative disorders. By utilizing genetic engineering, Empyrean aims to revolutionize healthcare by providing innovative treatments for severe neuropsychiatric and neurologic illnesses.